Rilmazolam is a triazolobenzodiazepine and the primary active metabolite of the prodrug Rilmazafone. It is used in pharmacological research to study benzodiazepine receptor interactions, sedation, and anxiolysis in both in vitro binding assays and in vivo animal models.
Molecular Weight:
400.26
CAS Number:
[50330-59-1]
Formula:
C19H15Cl2N5O
Target:
GABA Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
